I’ll believe it when I see it. I’ve made good money on ONVO in the past (I bought it when it was a $2/shr stock). But to print a large hormone producing living tissue with capillaries to boot seems a stretch to me.
The hard part will be keeping the capillaries open. This is a common problem with any organ transplant, or reattaching things like fingers or ears, you get massive clotting in the capillaries and tissue death sets in.
“But to print a large hormone producing living tissue with capillaries to boot seems a stretch to me.”
It’s a total “fabrication” - pun intended...
Here’s a very detailed look at the company and what it is doing.
http://seekingalpha.com/article/1848361-a-very-detailed-look-at-organovo